US 6329499
Methods for treatment of multiple sclerosis using peptide analogues of human myelin basic protein
expired A61KA61K38/00A61P
Quick answer
US patent 6329499 (Methods for treatment of multiple sclerosis using peptide analogues of human myelin basic protein) held by Neurocrine Biosciences, Inc. expires Mon Dec 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Neurocrine Biosciences, Inc.
- Grant date
- Tue Dec 11 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K38/00, A61P, A61P25/00, A61P25/02